# Eton Pharmaceuticals, Inc. (ETON) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Eton Pharmaceuticals, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ETON/mda/fy2025/): filed 2026-03-19; accession 0001437749-26-009059 (https://www.sec.gov/Archives/edgar/data/1710340/000143774926009059/eton20251231_10k.htm); latest 10-K
- [FY 2024 MD&A](/company/ETON/mda/fy2024/): filed 2025-03-18; accession 0001437749-25-008136 (https://www.sec.gov/Archives/edgar/data/1710340/000143774925008136/eton20241231_10k.htm)
- [FY 2023 MD&A](/company/ETON/mda/fy2023/): filed 2024-03-14; accession 0001437749-24-007853 (https://www.sec.gov/Archives/edgar/data/1710340/000143774924007853/eton20231231_10k.htm)
- [FY 2022 MD&A](/company/ETON/mda/fy2022/): filed 2023-03-16; accession 0001493152-23-007933 (https://www.sec.gov/Archives/edgar/data/1710340/000149315223007933/form10-k.htm)
- [FY 2021 MD&A](/company/ETON/mda/fy2021/): filed 2022-03-16; accession 0001493152-22-006990 (https://www.sec.gov/Archives/edgar/data/1710340/000149315222006990/form10-k.htm)

Back to /company/ETON/